Maxim Group analyst Michael Okunewitch has maintained their bullish stance on LCTX stock, giving a Buy rating on January 3.Stay Ahead of the ...

Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.

For the first time, a patient with type 1 diabetes has undergone an islet transplantation using genetically modified ...

Firm Capital Mortgage Investment Formally Declares Previously Announced Special Yr-End Div of C$0.056, Payable Jan. 15 With Dec. 31 Record Date Comtech Telecommunications Corp (CMTL) is expected to ...

Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.

Morgan Stanley likes financials, energy, real estate, and domestically-focused materials and consumer-goods companies.

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.